200 related articles for article (PubMed ID: 27414033)
1. Amyotrophic Lateral Sclerosis Type 20 - In Silico Analysis and Molecular Dynamics Simulation of hnRNPA1.
Krebs BB; De Mesquita JF
PLoS One; 2016; 11(7):e0158939. PubMed ID: 27414033
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Pathological Assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in Familial and Sporadic Amyotrophic Lateral Sclerosis.
Fifita JA; Zhang KY; Galper J; Williams KL; McCann EP; Hogan AL; Saunders N; Bauer D; Tarr IS; Pamphlett R; Nicholson GA; Rowe D; Yang S; Blair IP
Neurodegener Dis; 2017; 17(6):304-312. PubMed ID: 29131108
[TBL] [Abstract][Full Text] [Related]
3. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1.
Gilpin KM; Chang L; Monteiro MJ
Hum Mol Genet; 2015 May; 24(9):2565-77. PubMed ID: 25616961
[TBL] [Abstract][Full Text] [Related]
4. SOD1 in amyotrophic lateral sclerosis development - in silico analysis and molecular dynamics of A4F and A4V variants.
Da Silva ANR; Pereira GRC; Moreira LGA; Rocha CF; De Mesquita JF
J Cell Biochem; 2019 Oct; 120(10):17822-17830. PubMed ID: 31134679
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis of PFN1 related to amyotrophic lateral sclerosis.
Pereira GRC; Tellini GHAS; De Mesquita JF
PLoS One; 2019; 14(6):e0215723. PubMed ID: 31216283
[TBL] [Abstract][Full Text] [Related]
6. Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis.
Calini D; Corrado L; Del Bo R; Gagliardi S; Pensato V; Verde F; Corti S; Mazzini L; Milani P; Castellotti B; Bertolin C; Sorarù G; Cereda C; Comi GP; D'Alfonso S; Gellera C; Ticozzi N; Landers JE; Ratti A; Silani V;
Neurobiol Aging; 2013 Nov; 34(11):2695.e11-2. PubMed ID: 23827524
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics and protein frustration analysis of human fused in Sarcoma protein variants in Amyotrophic Lateral Sclerosis type 6: An In Silico approach.
Bonet LFS; Loureiro JP; Pereira GRC; Da Silva ANR; De Mesquita JF
PLoS One; 2021; 16(9):e0258061. PubMed ID: 34587215
[TBL] [Abstract][Full Text] [Related]
8. In silico analysis and molecular dynamics simulation of human superoxide dismutase 3 (SOD3) genetic variants.
Pereira GRC; Da Silva ANR; Do Nascimento SS; De Mesquita JF
J Cell Biochem; 2019 Mar; 120(3):3583-3598. PubMed ID: 30206983
[TBL] [Abstract][Full Text] [Related]
9. Does conserved domain SOD1 mutation has any role in ALS severity and therapeutic outcome?
Pal S; Tiwari A; Sharma K; Sharma SK
BMC Neurosci; 2020 Oct; 21(1):42. PubMed ID: 33036560
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of human SOD1 in amyotrophic lateral sclerosis.
Moreira LG; Pereira LC; Drummond PR; De Mesquita JF
PLoS One; 2013; 8(12):e81979. PubMed ID: 24312616
[TBL] [Abstract][Full Text] [Related]
11. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
Seelen M; Visser AE; Overste DJ; Kim HJ; Palud A; Wong TH; van Swieten JC; Scheltens P; Voermans NC; Baas F; de Jong JM; van der Kooi AJ; de Visser M; Veldink JH; Taylor JP; Van Es MA; van den Berg LH
Neurobiol Aging; 2014 Aug; 35(8):1956.e9-1956.e11. PubMed ID: 24612671
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing identifies a missense mutation in hnRNPA1 in a family with flail arm ALS.
Liu Q; Shu S; Wang RR; Liu F; Cui B; Guo XN; Lu CX; Li XG; Liu MS; Peng B; Cui LY; Zhang X
Neurology; 2016 Oct; 87(17):1763-1769. PubMed ID: 27694260
[TBL] [Abstract][Full Text] [Related]
13. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
Kim HJ; Kim NC; Wang YD; Scarborough EA; Moore J; Diaz Z; MacLea KS; Freibaum B; Li S; Molliex A; Kanagaraj AP; Carter R; Boylan KB; Wojtas AM; Rademakers R; Pinkus JL; Greenberg SA; Trojanowski JQ; Traynor BJ; Smith BN; Topp S; Gkazi AS; Miller J; Shaw CE; Kottlors M; Kirschner J; Pestronk A; Li YR; Ford AF; Gitler AD; Benatar M; King OD; Kimonis VE; Ross ED; Weihl CC; Shorter J; Taylor JP
Nature; 2013 Mar; 495(7442):467-73. PubMed ID: 23455423
[TBL] [Abstract][Full Text] [Related]
14. Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2).
George DC; Chakraborty C; Haneef SA; Nagasundaram N; Chen L; Zhu H
Theranostics; 2014; 4(4):366-85. PubMed ID: 24578721
[TBL] [Abstract][Full Text] [Related]
15. A mutation in the low-complexity domain of splicing factor hnRNPA1 linked to amyotrophic lateral sclerosis disrupts distinct neuronal RNA splicing networks.
Lee YJ; Rio DC
Genes Dev; 2024 Feb; 38(1-2):11-30. PubMed ID: 38182429
[TBL] [Abstract][Full Text] [Related]
16. Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach.
Islam MJ; Parves MR; Mahmud S; Tithi FA; Reza MA
Comput Biol Chem; 2019 Jun; 80():31-45. PubMed ID: 30884445
[TBL] [Abstract][Full Text] [Related]
17. In silico analysis of the V66M variant of human BDNF in psychiatric disorders: An approach to precision medicine.
De Oliveira CCS; Pereira GRC; De Alcantara JYS; Antunes D; Caffarena ER; De Mesquita JF
PLoS One; 2019; 14(4):e0215508. PubMed ID: 30998730
[TBL] [Abstract][Full Text] [Related]
18. Development of
Baziyar P; Seyedalipour B; Hosseinkhani S; Nazifi E
Iran J Biotechnol; 2022 Oct; 20(4):e3178. PubMed ID: 38344317
[TBL] [Abstract][Full Text] [Related]
19. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions.
Honda H; Hamasaki H; Wakamiya T; Koyama S; Suzuki SO; Fujii N; Iwaki T
Neuropathology; 2015 Feb; 35(1):37-43. PubMed ID: 25338872
[TBL] [Abstract][Full Text] [Related]
20. Nuclear pore pathology underlying multisystem proteinopathy type 3-related inclusion body myopathy.
Izumi R; Ikeda K; Niihori T; Suzuki N; Shirota M; Funayama R; Nakayama K; Warita H; Tateyama M; Aoki Y; Aoki M
Ann Clin Transl Neurol; 2024 Mar; 11(3):577-592. PubMed ID: 38158701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
